
Nalu Bio, a leading biotech firm, innovates CBD production via chemistry, ensuring eco-friendly, pure, and safe cannabinoids.
Nalu Bio, founded with a mission to revolutionize CBD production, focuses on developing cannabinoids through chemical synthesis rather than traditional plant extraction. This approach ensures the creation of pure, safe, and eco-friendly ingredients for companies seeking sustainable solutions. Nalu Bio's products cater to global consumer packaged goods (CPG) companies, offering cannabinoids for pain, anxiety, sleep, and weight management. Their innovative methods use significantly less land, water, and energy compared to conventional cultivation, aligning with their vision of environmental stewardship.
Notable figures affiliated with Nalu Bio include experts in biotechnology and organic chemistry who drive the company's pioneering research and development. The company has attracted significant investment from leading venture capital firms interested in sustainable biotech innovations. Nalu Bio's key achievements include being ranked as the top CBD producer on ingredient sourcing platforms and setting new standards for purity and quality in cannabinoid production. Their impact is marked by a substantial reduction in resource usage and a commitment to advancing health and wellness through cutting-edge science.
Companies similar to Nalu Bio include Hemp Synergistics, Next Frontier Biosciences, Astalake Biosystems and Biomedican.
Nalu Bio was founded in 2019.
Nalu Bio's headquarters is located in San Francisco, CA, US.
Nalu Bio's most recent funding round was for $12M (USD) in February 2023.
As of Feb 28, 2023, Nalu Bio has raised a total of $12.3M (USD).
Nalu Bio has 12 employees as of Feb 5, 2024.
Astalake Biosystems
astalakebio.com